Your session is about to expire
← Back to Search
Apollo System for ADHD
Study Summary
This trial will test how well the Apollo System works in reducing symptoms related to ADHD.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have been diagnosed with or suspected to have ADHD.I am between 8 and 17 years old.I've tried multiple treatments for over a year with little relief or have uncontrollable side effects.I have not started any new treatments in the last 30 days.My eligibility is not affected by my sex, race, or ethnicity.I have agreed to participate and understand it's first come, first serve.I have been diagnosed with or suspected to have ADHD.My current treatment hasn't significantly improved my symptoms or has caused severe side effects.I am between 8 and 17 years old.You need to have normal or corrected-to-normal vision to complete the cognitive task.
- Group 1: Commercial Apollo System Device
- Group 2: Sham Apollo System Device
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
Are enrollees currently being accepted for this medical trial?
"Affirmative. According to the information uploaded on clinicaltrials.gov, this medical experiment, which was initially advertised on March 18th 2022, is presently enrolling patients. The research team needs to recruit 100 people from a single location."
Is there an opportunity to participate in this medical experiment?
"This medical study is seeking one-hundred candidates between the ages of 8 and 17 that have been diagnosed with Attention Deficit Hyperactivity Disorder (ADHD). In order to qualify, participants must meet the following criteria: they should be aged at least eight years old and younger than eighteen; have experienced minimal symptom improvement or relief while on a single treatment plan for over twelve months; tried two or more different therapeutic methods without reaching their desired outcome; still in possession of symptoms despite taking medication; endure unwanted side effects due to pharmacological therapy. Moreover, enrollees are required to possess normal vision or corrected visual acuity necessary for completing cognitive tasks"
Does this research have an age-restriction, and if so, what is it?
"This clinical trial only allows participants between the ages of 8 and 17, in line with its pre-set inclusion standards."
To what extent has recruitment for this clinical trial been successful?
"Confirmed. Clinicaltrials.gov has evidence that this medical experiment is actively enrolling patients, which began posting on March 18th 2022 and was most recently updated on the 24th of March. There are 100 participants required in total from a single site."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger